髓系细胞可塑性在中枢神经系统自身免疫进化中的作用
该研究通过分析慢性活动性多发性硬化(MS)病灶的髓系细胞表型,并在实验性自身免疫性脑脊髓炎(EAE)中分离中枢神经系统(CNS)免疫细胞进行流式、遗传和功能分析,发现促炎型与替代极化型髓系细胞在病灶和病程中呈现异质性和可塑性,且Arg1+髓系细胞部分源自iNOS+前体且激活致病性T细胞能力缺陷。
要点
- MS病灶活跃脱髓鞘边缘以iNOS+促炎髓系细胞为主,静息核心富集CD206+巨噬细胞。
- EAE临床缓解前,CNS浸润髓系细胞和小胶质细胞从促炎标志物转向非炎性标志物。
- Arg1+髓系细胞部分源自iNOS+前体,且激活致病性T细胞能力低于Arg1-细胞。
核心结论
- CNS髓系细胞具有异质性和单细胞水平可塑性,并在自身免疫脱髓鞘病程中动态演化。
- 未来MS疾病修饰治疗可聚焦加速CNS髓系细胞从促炎向非炎性表型转变。
研究设计与样本
- 对慢性活动性MS病灶进行免疫组化分析髓系细胞表型。
- 在EAE加重期和缓解期分离CNS免疫细胞,进行流式细胞术、遗传和功能测定。
主要发现
- 表达iNOS的促炎表型髓系细胞见于慢性活动性MS病灶的活跃脱髓鞘边缘。
- 表达甘露糖受体(CD206)的巨噬细胞富集于静息病灶核心。
- EAE临床缓解前,CNS浸润髓系细胞及小胶质细胞从促炎标志物表达转向非炎性标志物表达。
- 表达替代谱系标志物精氨酸酶-1(Arg1)的小鼠CNS髓系细胞部分源自iNOS+前体。
- Arg1+髓系细胞相比Arg1-对应细胞,激活致病性T细胞的能力缺陷。
关键数值与推荐
- 慢性活动性MS病灶活跃脱髓鞘边缘检出iNOS+促炎表型髓系细胞。
- 慢性活动性MS病灶静息核心富集CD206+巨噬细胞。
- EAE临床缓解前夕,CNS髓系细胞和小胶质细胞从促炎标志物转向非炎性标志物。
- Arg1+小鼠CNS髓系细胞部分来自iNOS+前体,且激活致病性T细胞能力低于Arg1-细胞。
临床怎么用
- MS疾病修饰治疗可考虑靶向加速CNS髓系细胞从促炎向非炎性表型转化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Myeloid cells, including macrophages and dendritic cells, are a prominent component of central nervous system (CNS) infiltrates during multiple sclerosis (MS) and the animal model experimental autoimmune encephalomyelitis (EAE). Although myeloid cells are generally thought to be proinflammatory, alternatively polarized subsets can serve noninflammatory and/or reparative functions. Here we investigate the heterogeneity and biological properties of myeloid cells during central nervous system autoimmunity. METHODS: Myeloid cell phenotypes in chronic active MS lesions were analyzed by immunohistochemistry. In addition, immune cells were isolated from the CNS during exacerbations and remissions of EAE and characterized by flow cytometric, genetic, and functional assays. RESULTS: Myeloid cells expressing inducible nitric oxide synthase (iNOS), indicative of a proinflammatory phenotype, were detected in the actively demyelinating rim of chronic active MS lesions, whereas macrophages expressing mannose receptor (CD206), a marker of alternatively polarized human myeloid cells, were enriched in the quiescent lesion core. During EAE, CNS-infiltrating myeloid cells, as well as microglia, shifted from expression of proinflammatory markers to expression of noninflammatory markers immediately prior to clinical remissions. Murine CNS myeloid cells expressing the alternative lineage marker arginase-1 (Arg1) were partially derived from iNOS+ precursors and were deficient in activating encephalitogenic T cells compared with their Arg1- counterparts. INTERPRETATION: These observations demonstrate the heterogeneity of CNS myeloid cells, their evolution during the course of autoimmune demyelinating disease, and their plasticity on the single cell level. Future therapeutic strategies for disease modification in individuals with MS may be focused on accelerating the transition of CNS myeloid cells from a proinflammatory to a noninflammatory phenotype. Ann Neurol 2018;83:131-141.
引用
- Giles DA, Washnock-Schmid JM, Duncker PC, et al. Myeloid cell plasticity in the evolution of central nervous system autoimmunity. Ann Neurol. 2018. PMID: 29283442. doi:10.1002/ana.25128
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。